Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
21.81
+0.41 (1.92%)
At close: Dec 5, 2025, 4:00 PM EST
22.24
+0.43 (1.97%)
After-hours: Dec 5, 2025, 6:16 PM EST
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.29 billion as of December 5, 2025. Its market cap has increased by 6.39% in one year.
Market Cap
1.29B
Enterprise Value
817.29M
1-Year Change
6.39%
Ranking
Category
Stock Price
$21.81
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.29B, an increase of 32.89%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.27B | 15.53% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |